GO:0002246 wound healing involved in inflammatory response: Inflammatory Tissue Repair, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002246 describes the series of events that restore integrity to damaged tissue while contributing to an inflammatory response.
• The process is driven by coordinated waves of neutrophils, macrophages, lymphocytes, and fibroblasts that release growth factors and cytokines.
• Key molecular mediators include TGFB1, IL6, TNF, CXCL8, and VEGF, which link immune activation to tissue reconstruction.
• Dysregulation of GO:0002246 underlies chronic wounds, fibrosis, myocardial remodeling, and burn complications.
• microRNAs and growth factor signaling tightly regulate the resolution of inflammation during repair.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of genes in this GO term.
Description
GO:0002246, wound healing involved in inflammatory response, is a biological process defined as the series of events that restore integrity to damaged tissue that contribute to an inflammatory response. This term captures the intersection of hemostasis, immune cell recruitment, and tissue reconstruction that occurs after injury. It is distinct from generic wound healing because the inflammatory response is an obligatory component of the repair program, not merely a parallel event. Understanding this process is essential for researchers studying acute and chronic wounds, fibrosis, and organ repair. The inflammatory phase of wound healing is initiated by damage-associated molecular patterns and culminates in the recruitment of neutrophils and macrophages that clear debris and secrete cytokines and growth factors. These signals, in turn, activate fibroblasts, keratinocytes, and endothelial cells to rebuild the extracellular matrix and restore barrier function. Because the same pathways can become maladaptive in diabetes, burns, and myocardial infarction, GO:0002246 is a high-value target for mechanistic and translational studies.
wound healing involved in inflammatory response At A Glance
| GO ID | GO:0002246 |
|---|---|
| GO term | wound healing involved in inflammatory response |
| Ontology | biological_process |
| Synonym | healing during inflammatory response; inflammatory response wound healing |
| Major function | Restoration of tissue integrity through inflammation-coupled repair mechanisms |
| Key cell types | Neutrophils, macrophages, lymphocytes, fibroblasts, keratinocytes, endothelial cells |
| Key mediators | TGFB1, IL6, TNF, CXCL8, VEGF, PDGF |
| Related processes | Hemostasis, immune cell recruitment, angiogenesis, extracellular matrix remodeling |
| Disease relevance | Chronic wounds, diabetic ulcers, fibrosis, myocardial remodeling, burn injury |
What Is GO:0002246?
In plain terms, GO:0002246 describes how the body repairs a wound while simultaneously running an inflammatory response. The QuickGO definition states that it is the series of events that restore integrity to damaged tissue that contribute to an inflammatory response. This includes hemostasis, immune cell infiltration, cytokine and growth factor release, fibroblast activation, angiogenesis, and matrix remodeling, all of which are intertwined with inflammation.
Why Is wound healing involved in inflammatory response Important in Cell Biology?
GO:0002246 is important because it defines the mechanistic bridge between innate immunity and tissue reconstruction. When this process is efficient, it restores barrier function and organ integrity; when it is dysregulated, it drives chronic non-healing wounds, excessive fibrosis, and adverse remodeling after myocardial infarction. Because the inflammatory response is an integral part of repair, targeting its mediators can either accelerate healing or prevent pathological scarring, making this GO term a central framework for wound biology research.
• Provides a unified framework for studying how inflammation contributes to tissue repair rather than merely accompanying it.
• Explains why diabetic wounds fail to heal: persistent inflammation and impaired macrophage function disrupt the repair sequence.
• Links burn injury outcomes to immune and regenerative responses that determine scarring and infection risk.
• Highlights microRNA-based regulation of inflammatory wound healing as a therapeutic avenue.
• Connects growth factor and cytokine signaling to fibroblast and keratinocyte activation during repair.
• Supports research on myocardial repair, where inflammatory resolution is required for scar formation and remodeling.
• Identifies smoking and nicotine as modifiable factors that impair healing and increase infection risk.
• Guides development of CRISPR models to test causal roles of individual genes in repair.
• Informs biomarker discovery for chronic wounds and fibrosis.
• Provides a conceptual basis for anti-inflammatory strategies that preserve, rather than block, tissue repair.
What Happens During wound healing involved in inflammatory response?
Hemostasis and Immediate Inflammatory Trigger
In simple terms: When tissue is injured, bleeding stops and danger signals wake up the immune system.
After injury, platelet aggregation and coagulation form a provisional matrix that serves as a scaffold for incoming immune cells. Damaged cells release damage-associated molecular patterns that activate resident macrophages and mast cells, initiating the inflammatory response that is integral to GO:0002246. This early phase establishes the chemotactic gradient that recruits neutrophils and monocytes to the wound site.
Immune Cell Recruitment and Cytokine Release
In simple terms: Immune cells rush to the wound and release signals that coordinate repair.
Neutrophils arrive first to debride the wound and release proteases and reactive oxygen species. Macrophages then dominate the scene, switching from a pro-inflammatory to a pro-reparative phenotype that secretes growth factors such as TGFB1, VEGF, and PDGF. Cytokines including IL6, TNF, and CXCL8 amplify and shape this response, and their balance determines whether healing progresses or becomes chronic.
Fibroblast Activation and Matrix Deposition
In simple terms: Repair cells build new tissue to fill the wound.
Fibroblasts migrate into the wound and synthesize collagen and other extracellular matrix components. In diabetic wounds, fibroblast dysfunction and immunomodulatory imbalance contribute to refractory healing. Growth factors released by macrophages and platelets, including TGFB1 and PDGF, drive fibroblast proliferation and myofibroblast differentiation, which are essential for wound contraction and closure.
Angiogenesis and Tissue Remodeling
In simple terms: New blood vessels grow and the repaired tissue is reshaped.
VEGF and other angiogenic factors promote neovascularization to restore oxygen and nutrient supply to the healing tissue. Matrix metalloproteinases remodel the provisional matrix, and the inflammatory response must resolve for remodeling to proceed. Persistent inflammation impairs this transition and is a hallmark of chronic wounds and fibrosis.
Resolution of Inflammation and Scar Maturation
In simple terms: The immune response winds down so the repair can finish.
Resolution involves clearance of apoptotic neutrophils, macrophage polarization toward a reparative phenotype, and downregulation of pro-inflammatory cytokines. microRNAs regulate this inflammatory response during wound healing, and their dysregulation can prolong inflammation. In myocardial injury, timely resolution is required for scar formation and prevention of adverse remodeling. Failure of resolution leads to chronic wounds, as seen in diabetic and burn patients.
Key Genes Involved in GO:0002246 wound healing involved in inflammatory response
The following genes and proteins are central mediators of GO:0002246, spanning immune recruitment, growth factor signaling, and matrix remodeling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Drives fibroblast activation and matrix deposition | Core mediator of repair and fibrosis |
| IL6 | Pro-inflammatory cytokine that amplifies immune recruitment | Target for modulating inflammatory phase |
| TNF | Promotes inflammation and immune cell activation | Key node in chronic wound inflammation |
| CXCL8 | Neutrophil chemoattractant | Regulates early immune infiltration |
| VEGF | Promotes angiogenesis during repair | Essential for revascularization of healing tissue |
| PDGF | Stimulates fibroblast proliferation and migration | Growth factor therapy candidate |
| MMP9 | Degrades extracellular matrix during remodeling | Implicated in chronic wound imbalance |
| ARG1 | Marker of reparative macrophages | Indicator of macrophage polarization |
| IL10 | Anti-inflammatory cytokine promoting resolution | Regulates transition to repair phase |
| CCL2 | Monocyte chemoattractant | Recruits macrophages to wound site |
| COL1A1 | Major collagen component of repaired matrix | Readout of fibroblast function |
| ACTA2 | Myofibroblast marker for wound contraction | Assesses contractile repair capacity |
| HIF1A | Mediates hypoxia response in healing tissue | Links oxygen sensing to angiogenesis |
| NFKB1 | Transcription factor driving inflammatory gene expression | Central regulator of inflammatory phase |
| STAT3 | Transduces cytokine signals in repair cells | Modulates keratinocyte and fibroblast responses |
| MIR21 | microRNA that fine-tunes inflammatory signaling | Therapeutic target in wound inflammation |
| MIR146A | Negative regulator of inflammatory pathways | Controls resolution of inflammation |
How Is wound healing involved in inflammatory response Regulated?
GO:0002246 is regulated at multiple levels. Cytokine and growth factor signaling through NF-kB and STAT3 controls the intensity of the inflammatory phase. microRNAs such as miR-21 and miR-146a provide post-transcriptional control of inflammatory mediators during wound healing. Macrophage polarization from pro-inflammatory to reparative states is a key regulatory checkpoint, and its disruption leads to chronic wounds. Environmental factors such as smoking and nicotine impair healing and increase infection risk, further modulating this process.
wound healing involved in inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB1 | Fibrosis and impaired wound closure | Knockout and overexpression in fibroblasts |
| IL6 | Chronic inflammation in diabetic wounds | Point mutation and knockout in macrophages |
| TNF | Persistent inflammation and tissue damage | Knockout in mouse wound models |
| VEGF | Impaired angiogenesis in chronic wounds | Knock-in reporter for angiogenesis |
| MIR146A | Dysregulated resolution of inflammation | Overexpression and knockout in keratinocytes |
Diabetic Wound Healing
Diabetes impairs multiple steps of GO:0002246, including immune cell recruitment, macrophage polarization, and fibroblast function, leading to chronic non-healing wounds in soft and hard oral tissues as well as skin. Persistent inflammation and defective resolution are central to this pathology.
Myocardial Injury and Remodeling
After myocardial infarction, the inflammatory response is required for clearance of dead tissue and formation of a stable scar, but excessive or prolonged inflammation drives adverse remodeling and heart failure. GO:0002246 provides a framework for understanding the balance between reparative and maladaptive inflammation in the heart.
Burn Injury and Infection
Burn injury triggers a massive immune and regenerative response, and dysregulation of GO:0002246 contributes to scarring, infection, and delayed healing. The interplay between inflammation and tissue regeneration after burns is a major determinant of clinical outcome.
Surgical Wound Complications and Smoking
Smoking and nicotine replacement therapy impair wound healing and increase infection risk after surgery, acting through vasoconstriction and inflammatory dysregulation. These effects highlight modifiable risk factors that influence GO:0002246 in clinical settings.
From wound healing involved in inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TGFB1 impair wound closure? | CRISPR knockout in fibroblasts or mice |
| Does a point mutation in IL6 alter inflammatory signaling? | CRISPR point mutation in macrophages |
| Can a tagged VEGF reporter track angiogenesis? | Knock-in of fluorescent tag at VEGF locus |
| Does miR-146a overexpression resolve inflammation? | CRISPR overexpression in keratinocytes |
| Is macrophage ARG1 required for reparative polarization? | Knockout in macrophage cell lines |
| Does smoking-related gene signature alter healing? | Knock-in of risk variants in epithelial cells |
How to Study the wound healing involved in inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Time-course analysis of wound healing |
| Single-cell RNA-seq | Cell-type-specific expression | Immune and fibroblast heterogeneity |
| Immunohistochemistry | Protein localization in tissue | Spatial mapping of inflammation |
| Scratch assay | Cell migration capacity | In vitro wound closure |
| Collagen gel contraction | Fibroblast contractility | Myofibroblast function |
| ELISA/multiplex | Cytokine and growth factor levels | Inflammatory mediator quantification |
| CRISPR screening | Gene requirement for repair | Discovery of novel regulators |
| Flow cytometry | Immune cell populations | Macrophage polarization analysis |
Transcriptomic Profiling of Wound Tissue
RNA-seq of wound tissue at multiple time points reveals the dynamic expression of cytokines, growth factors, and matrix genes that define GO:0002246. This approach identifies candidate regulators of the inflammatory-to-reparative transition.
Spatial and Single-Cell Imaging
Immunohistochemistry and single-cell RNA-seq map the spatial distribution of immune cells and fibroblasts in healing wounds, revealing how inflammation is organized within tissue. These methods are essential for linking gene expression to tissue architecture.
Functional Assays for Repair
Scratch assays, collagen gel contraction assays, and in vivo wound closure models measure the functional output of GO:0002246. These assays can be combined with CRISPR perturbations to test causality.
Cytokine and Growth Factor Profiling
ELISA and multiplex cytokine arrays quantify IL6, TNF, TGFB1, and VEGF levels in wound exudates or conditioned media, providing a molecular readout of the inflammatory response.
How CRISPR Can Be Used to Study GO:0002246 wound healing involved in inflammatory response
Knockout
CRISPR knockout of candidate genes such as TGFB1, IL6, or MIR146A in fibroblasts or macrophages can test whether they are required for wound healing and inflammatory resolution. Knockout models are particularly useful for distinguishing causal drivers from correlative markers.
Point Mutation
Point mutations can model disease-associated variants in inflammatory mediators, allowing researchers to assess how subtle changes in protein function alter GO:0002246. This is valuable for studying cytokine signaling and receptor variants.
Knock-in
Knock-in of fluorescent or epitope tags at endogenous loci enables real-time tracking of proteins such as VEGF or ARG1 during wound healing. Tagged knock-in models preserve native regulation and are ideal for imaging studies.
Overexpression
CRISPR-mediated overexpression of anti-inflammatory or pro-reparative genes, such as IL10 or miR-146a, can test whether enhancing their activity accelerates resolution of inflammation and improves healing. Overexpression models are also used to study gain-of-function mechanisms in fibrosis.
How EDITGENE Supports wound healing involved in inflammatory response Research
Researchers studying wound healing involved in inflammatory response-related genes often need to determine whether a candidate gene is causally involved in repair or merely a bystander. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for wound healing involved in inflammatory response research.
Frequently Asked Questions About wound healing involved in inflammatory response
What is GO:0002246?
GO:0002246 is the biological process of wound healing involved in inflammatory response, defined as the series of events that restore integrity to damaged tissue that contribute to an inflammatory response.
What genes are involved in wound healing involved in inflammatory response?
Key genes include TGFB1, IL6, TNF, CXCL8, VEGF, PDGF, MMP9, ARG1, IL10, CCL2, COL1A1, ACTA2, HIF1A, NFKB1, STAT3, MIR21, and MIR146A.
Why is inflammation important for wound healing?
Inflammation is required to clear debris, recruit immune cells, and release growth factors that drive tissue reconstruction; without it, repair is impaired.
How does diabetes affect GO:0002246?
Diabetes impairs immune cell recruitment, macrophage polarization, and fibroblast function, leading to chronic non-healing wounds.
What role do macrophages play in wound healing?
Macrophages switch from pro-inflammatory to reparative phenotypes and secrete growth factors such as TGFB1 and VEGF that coordinate repair.
Can CRISPR be used to study wound healing genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in GO:0002246.
What microRNAs regulate inflammatory wound healing?
miR-21 and miR-146a are among the microRNAs that fine-tune inflammatory signaling during wound healing.
How does smoking affect wound healing?
Smoking and nicotine impair healing and increase infection risk through vasoconstriction and inflammatory dysregulation.
What methods are used to study GO:0002246?
RNA-seq, single-cell RNA-seq, immunohistochemistry, scratch assays, ELISA, flow cytometry, and CRISPR screens are commonly used.
What diseases are linked to defective inflammatory wound healing?
Diabetic ulcers, myocardial remodeling after infarction, burn complications, fibrosis, and surgical wound infections are linked to dysregulation of this process.
Conclusion
GO:0002246, wound healing involved in inflammatory response, is a central biological process that integrates immune activation with tissue reconstruction. Its dysregulation underlies chronic wounds, fibrosis, and adverse remodeling, making it a high-priority area for mechanistic and translational research. CRISPR-based models and multi-omics methods now allow researchers to dissect the causal roles of individual genes and pathways within this process, accelerating the development of therapies that promote efficient healing without pathological inflammation.
References
- 1. Peña OA et al.. 2024. Cellular and molecular mechanisms of skin wound healing.. Nat Rev Mol Cell Biol 25(8):599-616 PMID: 38528155
- 2. Ko KI et al.. 2021. Diabetic wound healing in soft and hard oral tissues.. Transl Res 236:72-86 PMID: 33992825
- 3. Frangogiannis NG. 2014. The inflammatory response in myocardial injury, repair, and remodelling.. Nat Rev Cardiol 11(5):255-65 PMID: 24663091
- 4. Liu Y et al.. 2022. Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing.. Front Immunol 13:918223 PMID: 35990622
- 5. Barrientos S et al.. 2008. Growth factors and cytokines in wound healing.. Wound Repair Regen 16(5):585-601 PMID: 19128254
- 6. Burgess M et al.. 2022. The Immune and Regenerative Response to Burn Injury.. Cells 11(19) PMID: 36231034
- 7. Jiang Y et al.. 2022. The Role of microRNA in the Inflammatory Response of Wound Healing.. Front Immunol 13:852419 PMID: 35386721
- 8. Sørensen LT. 2012. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review.. Ann Surg 255(6):1069-79 PMID: 22566015
